Pictet Asset Management (Switzerland)’s NeoGenomics NEO Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$212K	Hold	13,166	–	–	﹤0.01%	1696
2023 Q1	$229K	Hold	13,166	–	–	﹤0.01%	1665
2022 Q4	$122K	Buy	+13,166	New	+$123K	﹤0.01%	1825
2022 Q1	–	Sell	-7,615	Closed	-$260K	–	1722
2021 Q4	$260K	Hold	7,615	–	–	﹤0.01%	1469
2021 Q3	$367K	Buy	+7,615	New	+$353K	﹤0.01%	1325

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s NEO Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its NeoGenomics (NEO) position steady in Q2 2023 at 13,166 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Pictet Asset Management (Switzerland) first reported a position in NEO in Q3 2021 and has held it in 5 quarters since. The position peaked at $367K in Q3 2021. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

Pictet Asset Management (Switzerland) held 13,166 shares of NeoGenomics worth $212K as of Q2 2023.
Pictet Asset Management (Switzerland) left its NeoGenomics share count unchanged in Q2 2023.
NeoGenomics made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1696 holding.
Pictet Asset Management (Switzerland) first reported a position in NeoGenomics in Q3 2021 and has held it in 5 quarters since.
Pictet Asset Management (Switzerland)'s NeoGenomics position peaked at $367K in Q3 2021.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.